Ameliorating the age at onset and disease progression in Huntington disease
Citation Manager Formats

Article Information
- First Published May 9, 2018.
Article Versions
- Previous version (May 9, 2018 - 12:50).
- You are viewing the most recent version of this article.
Author Information
- Patrick J. Morrison, CBE, MD, DSc and
- Martin B. Delatycki, MBBS, FRACP, PhD
- Patrick J. Morrison, CBE, MD, DSc and
NONE
NONE
NONE
The Oncologist, Section editor, 2007-2017. uncompensated.
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Martin B. Delatycki, MBBS, FRACP, PhD
NONE
NONE
NONE
Associate Editor BMC Neurology 2008 to current Associate Editor Pediatric Genetics 2013 to current
NONE
NONE
Victorian Clinical Genetics Services- Medical Director (Not for profit organisation) Murdoch Children's Research Institute- Director, Bruce Lefroy Centre (Not for profit organisation)
NONE
NONE
NONE
NONE
Reata- provide funding for a clinical trial of RTA408 for the treatment of Friedreich ataxia. I do not receive any personal remuneration from this.
Grants from National Health and Medical Research Council, Friedreich Ataxia Research Association and Friedreich Ataxia Research Alliance provides funding for my research but not for my salary
Honorary Professor- University of Melbourne Honorary Professor- Monash University
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- From the Department of Genetic Medicine (P.J.M.), Belfast HSC Trust; Centre for Cancer Research and Cell Biology (P.J.M.), Queens University of Belfast, UK; Victorian Clinical Genetics Services (M.D.) and Bruce Lefroy Centre (M.D.), Murdoch Children's Research Institute, Parkville, Australia.
- Correspondence
Prof. Morrison patrick.morrison{at}belfasttrust.hscni.net
Article usage
Disputes & Debates: Rapid online correspondence
NOTE: All contributors' disclosures must be entered and current in our database before comments can be posted. Enter and update disclosures at http://submit.neurology.org. Exception: replies to comments concerning an article you originally authored do not require updated disclosures.
- Stay timely. Submit only on articles published within the last 8 weeks.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- 200 words maximum.
- 5 references maximum. Reference 1 must be the article on which you are commenting.
- 5 authors maximum. Exception: replies can include all original authors of the article.
- Submitted comments are subject to editing and editor review prior to posting.